Page last updated: 2024-08-26

arsenic and Leukemia, Pre-B-Cell

arsenic has been researched along with Leukemia, Pre-B-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alikarami, F; Kazemi, A; Teremmahi Ardestanii, M; Toosi, B; Zaker, F1

Other Studies

1 other study(ies) available for arsenic and Leukemia, Pre-B-Cell

ArticleYear
VS-5584 as a PI3K/mTOR inhibitor enhances apoptotic effects of subtoxic dose arsenic trioxide via inhibition of NF-κB activity in B cell precursor-acute lymphoblastic leukemia.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 102

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Morpholines; NF-kappa B; Oxides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Purines; TOR Serine-Threonine Kinases

2018